Arvinas Inc (ARVN) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Over the past 4 years, Arvinas Inc has achieved a revenue compound annual growth rate (CAGR) of 78.6%, while earnings have grown at 13.6% CAGR.
Historical revenue and profitability trends for Arvinas Inc
The chart above illustrates Arvinas Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Arvinas Inc's business.
How efficiently Arvinas Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Arvinas Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Arvinas Inc to continue focusing on sustainable operations. The consensus analyst rating is 4.0476 based on 21 analysts.
Based on our comprehensive analysis, Arvinas Inc (ARVN) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Arvinas Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Arvinas Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: ARVN Valuation, ARVN Dividend, ARVN Financial Health
Compare: ARVN vs AAPL, ARVN vs MSFT, ARVN vs GOOGL